NAUT – nautilus biotechnology, inc. (US:NASDAQ)
Stock Stats
News
Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform [Yahoo! Finance]
Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform
Nautilus Biotechnology Appoints Proteomics Commercial Leader Amber Faust as Vice President of Sales
Nautilus Biotechnology (NAUT) had its price target raised by Guggenheim from $2.50 to $4.00. They now have a "buy" rating on the stock.
Nautilus Biotechnology Q4 Earnings Call Highlights [Yahoo! Finance]
Form SCHEDULE 13D/A Nautilus Biotechnology, Filed by: Mallick Parag
Form SCHEDULE 13D/A Nautilus Biotechnology, Filed by: Patel Sujal M
Form 4 Nautilus Biotechnology, For: Mar 04 Filed by: Patel Sujal M
Form 4 Nautilus Biotechnology, For: Mar 02 Filed by: Mowry Anna
Form 4 Nautilus Biotechnology, For: Mar 02 Filed by: Mallick Parag
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.